Literature DB >> 4029407

Allopurinol mouthwashes and 5-fluorouracil induced oral toxicity.

P I Clark, M L Slevin.   

Abstract

Allopurinol has been shown to decrease the gastro-intestinal and bone marrow toxicity of 5-fluorouracil. In an attempt to diminish mucositis resulting from 5-fluorouracil administration, whilst not affecting its systemic anti-tumour activity, an allopurinol mouthwash has been used. In six patients who experienced mucositis when treated initially with 5-fluorouracil, the use of an allopurinol mouthwash with subsequent courses resulted in a reduction of oral toxicity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4029407

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  7 in total

1.  Oral complications of cancer.

Authors:  F M Calman; J Langdon
Journal:  BMJ       Date:  1991-03-02

2.  Salivary passage of 5-fluorouracil during continuous infusion.

Authors:  G Milano; A Thyss; J Santini; M Frenay; E Francois; M Schneider; F Demard
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 3.  Systematic review of miscellaneous agents for the management of oral mucositis in cancer patients.

Authors:  Siri Beier Jensen; Virginia Jarvis; Yehuda Zadik; Andrei Barasch; Anura Ariyawardana; Allan Hovan; Noam Yarom; Rajesh V Lalla; Joanne Bowen; Sharon Elad
Journal:  Support Care Cancer       Date:  2013-07-31       Impact factor: 3.603

4.  Concurrent allopurinol and 5-fluorouracil: 5-fluoro-2'-deoxyuridylate formation and thymidylate synthase inhibition in rat colon carcinoma and in regenerating rat liver.

Authors:  M Berne; B Gustavsson; O Almersjö; C P Spears; J Waldenström
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

Review 5.  Cancer therapy and oral mucositis. An appraisal of drug prophylaxis.

Authors:  C J Verdi
Journal:  Drug Saf       Date:  1993-09       Impact factor: 5.606

6.  A less toxic regimen of 5-fluorouracil and high-dose folinic acid for advanced gastrointestinal adenocarcinomas.

Authors:  P W Johnson; P I Thompson; M T Seymour; N P Deasy; R C Thuraisingham; M L Slevin; P F Wrigley
Journal:  Br J Cancer       Date:  1991-09       Impact factor: 7.640

7.  5-fluorouracil and folinic acid-induced mucositis: no effect of oral glutamine supplementation.

Authors:  S A Jebb; R J Osborne; T S Maughan; N Mohideen; P Mack; D Mort; M D Shelley; M Elia
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.